Metabolic (cytoprotective) therapy of menopausal disturbances

The paper presents modern views on cardiovascular aspects of menopause and metabolic therapy of menopausal disturbances with meldonium (Mildronate®). The role of estrogen deficiency in climacteric disturbance development, key pathogenetic mechanisms of menopausal metabolic syndrome (MS), and relevan...

Full description

Bibliographic Details
Main Authors: S. N. Tolstov, V. B. Mychka
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2011-06-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1835

Similar Items